Hazardous material removal continues Friday in fire-damaged areas of the Pacific Palisades and Pasadena, a day after former ...

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s blockbuster Dupixent. Last year, BMS reported a phase 3 trial in eosinophilic ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Regional airports like Palm Springs International Airlines are trying to expand international offerings after traffic ...

On Thursday, former Vice President Kamala Harris toured the Palisades fire zone with Supervisor Lindsay Horvath, while EPA ...

Beaver Stadium looks drastically different, as the West side's press box and upper seating deck have been removed.

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

Kura and Kyowa used the announcement to confirm that they are on track to file a new drug approval application with the FDA ...